FDA information regarding Biosimilars

Posted in Latest News on August 26, 2013.

The FDA has created a pathway for the approval of biosimilar products, but has not yet approved a biological product as biosimilar or interchangeable. There is no date-certain for when these products will be approved—some estimates are three to five years.
The Board of Pharmacy has established a link on its website to the FDA pathway for approval of biosimilar biological products.



More Latest News

Meningococcal Disease and Vaccines
April 14, 2022

The Florida Department of Health (FDOH) is responding to an outbreak of meningococcal disease in some areas of Florida. Continue reading


Second Quarter Performance Report
April 12, 2022

Released for the
2021 – 2022 Fiscal Year Continue reading